Amy Peterson
2019 - BeiGene, Ltd.
In 2019, Amy Peterson earned a total compensation of $1.4M as Former Chief Medical Officer, Immuno, oncology at BeiGene, Ltd., a 58% decrease compared to previous year.
Compensation breakdown
| Option Awards | $938,537 |
|---|---|
| Salary | $37,051 |
| Other | $451,654 |
| Total | $1,427,242 |
Peterson received $938.5K in option awards, accounting for 66% of the total pay in 2019.
Peterson also received $37.1K in salary and $451.7K in other compensation.
Rankings
In 2019, Amy Peterson's compensation ranked 7,558th out of 13,971 executives tracked by ExecPay. In other words, Peterson earned more than 45.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,558 out of 13,971 | 46th |
Division Manufacturing | 2,941 out of 5,701 | 48th |
Major group Chemicals And Allied Products | 1,109 out of 2,200 | 50th |
Industry group Drugs | 945 out of 1,886 | 50th |
Industry Pharmaceutical Preparations | 699 out of 1,398 | 50th |
Source: SEC filing on April 28, 2020.
Peterson's colleagues
We found four more compensation records of executives who worked with Amy Peterson at BeiGene, Ltd. in 2019.
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019